Alkermes
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
CEORichard F. Pops
CEORichard F. Pops
Employees1,800
Employees1,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2011
Founded2011
Employees1,800
Employees1,800
ALKS Key Statistics
Market cap4.99B
Market cap4.99B
Price-Earnings ratio14.50
Price-Earnings ratio14.50
Dividend yield—
Dividend yield—
Average volume1.81M
Average volume1.81M
High today$30.46
High today$30.46
Low today$29.97
Low today$29.97
Open price$30.14
Open price$30.14
Volume1.39M
Volume1.39M
52 Week high$36.45
52 Week high$36.45
52 Week low$22.97
52 Week low$22.97
ALKS News
Simply Wall St 4d
Alkermes shareholders have earned a 9.3% CAGR over the last five yearsWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price r...
Analyst ratings
69%
of 16 ratingsBuy
68.8%
Hold
31.3%
Sell
0%
People also own
Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.